A detailed history of Salem Investment Counselors Inc transactions in Organon & Co. stock. As of the latest transaction made, Salem Investment Counselors Inc holds 1,787 shares of OGN stock, worth $26,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,787
Previous 1,937 7.74%
Holding current value
$26,733
Previous $40,000 15.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$18.65 - $23.03 $2,797 - $3,454
-150 Reduced 7.74%
1,787 $34,000
Q2 2024

Jul 11, 2024

SELL
$17.45 - $21.96 $628 - $790
-36 Reduced 1.82%
1,937 $40,000
Q1 2024

Apr 11, 2024

SELL
$13.78 - $18.8 $1,612 - $2,199
-117 Reduced 5.6%
1,973 $37,000
Q4 2023

Jan 16, 2024

SELL
$10.95 - $17.32 $13,359 - $21,130
-1,220 Reduced 36.86%
2,090 $30,000
Q3 2023

Oct 04, 2023

SELL
$16.59 - $23.77 $4,346 - $6,227
-262 Reduced 7.33%
3,310 $57,000
Q2 2023

Jul 19, 2023

SELL
$19.27 - $24.63 $20,676 - $26,427
-1,073 Reduced 23.1%
3,572 $74,000
Q1 2023

May 11, 2023

SELL
$21.42 - $32.08 $45,453 - $68,073
-2,122 Reduced 31.36%
4,645 $109,000
Q4 2022

Feb 15, 2023

SELL
$23.31 - $28.61 $1,981 - $2,431
-85 Reduced 1.24%
6,767 $189,000
Q3 2022

Nov 09, 2022

SELL
$23.4 - $34.25 $9,664 - $14,145
-413 Reduced 5.68%
6,852 $160,000
Q2 2022

Aug 17, 2022

SELL
$31.66 - $38.9 $9,498 - $11,670
-300 Reduced 3.97%
7,265 $245,000
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $344,328 - $445,082
-11,308 Reduced 59.92%
7,565 $264,000
Q4 2021

Feb 15, 2022

SELL
$28.67 - $37.13 $102,351 - $132,554
-3,570 Reduced 15.91%
18,873 $575,000
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $112,057 - $139,494
-3,914 Reduced 14.85%
22,443 $736,000
Q2 2021

Aug 17, 2021

BUY
$28.45 - $38.0 $749,856 - $1 Million
26,357 New
26,357 $798,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.8B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.